Rhythm Pharmaceuticals, Inc.
Public
RYTM
SectorHealthcare
CountryUnited States
Market cap5.76B
A biopharmaceutical company developing targeted therapies for the treatment of rare genetic obesity and neuroendocrine disorders.
